Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Hsing Chen

Showing results (201-210 of 228) with videos related to

Pageof 23
Sort By:
Rheumatology (Oxford, England)|August 15, 2020
Which factors predict discordance between a patient and physician on a gout flare?Aprajita Jagpal, Elizabeth J Rahn, Amy S Mudano, et al.
Seminars in Arthritis and Rheumatism|December 19, 2025
Factors associated with rapid spinal radiographic progression in patients with axial spondyloarthritis: A hospital-based retrospective cohort study with mSASSS scoring using deep learning modelChung-Mao Kao, Yi-Hsing Chen, Wen-Nan Huang, et al.
International Journal of Rheumatic Diseases|December 19, 2025
Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single-Center Retrospective StudyShu-Ping Han, Yi-Hsing Chen, Wen-Nan Huang, et al.
Rheumatology (Oxford, England)|March 11, 2021
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Vera Golder, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
The Lancet. Rheumatology|January 23, 2024
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort studyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Pageof 23

Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
Rheumatology (Oxford, England)|August 15, 2020
Which factors predict discordance between a patient and physician on a gout flare?Aprajita Jagpal, Elizabeth J Rahn, Amy S Mudano, et al.
Seminars in Arthritis and Rheumatism|December 19, 2025
Factors associated with rapid spinal radiographic progression in patients with axial spondyloarthritis: A hospital-based retrospective cohort study with mSASSS scoring using deep learning modelChung-Mao Kao, Yi-Hsing Chen, Wen-Nan Huang, et al.
International Journal of Rheumatic Diseases|December 19, 2025
Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single-Center Retrospective StudyShu-Ping Han, Yi-Hsing Chen, Wen-Nan Huang, et al.
Rheumatology (Oxford, England)|March 11, 2021
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Vera Golder, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
The Lancet. Rheumatology|January 23, 2024
Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort studyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Pageof 23